Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Mahler

Showing results (11-20 of 202) with videos related to

Pageof 21
Sort By:
Arthritis Research & Therapy|April 9, 2009
The changing landscape of the clinical value of the PM/Scl autoantibody systemMichael Mahler, Marvin J Fritzler
Arthritis Research & Therapy|September 4, 2009
AIT test has no problem in the detection of anti-ribosomal P--authors' responseMichael Mahler, Marvin J Fritzler
Annals of the New York Academy of Sciences|February 12, 2010
Epitope specificity and significance in systemic autoimmune diseasesMichael Mahler, Marvin J Fritzler
The Journal of Rheumatology|March 3, 2018
Diagnostic Utility of Anticarbamylated Protein Antibodies as Measured Using Carbamylated Fetal Calf SerumMichael Mahler, Marvin J Fritzler
Nature Clinical Practice. Rheumatology|February 15, 2007
Anti-dsDNA antibody testing in the clinic: Farr or ELISA?Michael Mahler, Marvin J Fritzler
Autoimmunity Reviews|December 24, 2008
PM1-Alpha ELISA: the assay of choice for the detection of anti-PM/Scl autoantibodies?Michael Mahler, Marvin J Fritzler
Autoimmunity Reviews|June 6, 2012
Closing the serological gap: promising novel biomarkers for the early diagnosis of rheumatoid arthritisLeendert A Trouw, Michael Mahler
The Journal of Rheumatology|July 3, 2014
Antinuclear antibodies in childrenMichael Mahler, Marvin J Fritzler
Clinical & Developmental Immunology|January 11, 2013
The clinical significance of the dense fine speckled immunofluorescence pattern on HEp-2 cells for the diagnosis of systemic autoimmune diseasesMichael Mahler, Marvin J Fritzler
Annals of the Rheumatic Diseases|August 1, 2019
Augmented versus artificial intelligence for stratification of patients with myositisMichael Mahler, Brenden Rossin, Olga Kubassova
Pageof 21

Showing results (11-20 of 202) with videos related to

Sort By:
Pageof 21
Arthritis Research & Therapy|April 9, 2009
The changing landscape of the clinical value of the PM/Scl autoantibody systemMichael Mahler, Marvin J Fritzler
Arthritis Research & Therapy|September 4, 2009
AIT test has no problem in the detection of anti-ribosomal P--authors' responseMichael Mahler, Marvin J Fritzler
Annals of the New York Academy of Sciences|February 12, 2010
Epitope specificity and significance in systemic autoimmune diseasesMichael Mahler, Marvin J Fritzler
The Journal of Rheumatology|March 3, 2018
Diagnostic Utility of Anticarbamylated Protein Antibodies as Measured Using Carbamylated Fetal Calf SerumMichael Mahler, Marvin J Fritzler
Nature Clinical Practice. Rheumatology|February 15, 2007
Anti-dsDNA antibody testing in the clinic: Farr or ELISA?Michael Mahler, Marvin J Fritzler
Autoimmunity Reviews|December 24, 2008
PM1-Alpha ELISA: the assay of choice for the detection of anti-PM/Scl autoantibodies?Michael Mahler, Marvin J Fritzler
Autoimmunity Reviews|June 6, 2012
Closing the serological gap: promising novel biomarkers for the early diagnosis of rheumatoid arthritisLeendert A Trouw, Michael Mahler
The Journal of Rheumatology|July 3, 2014
Antinuclear antibodies in childrenMichael Mahler, Marvin J Fritzler
Clinical & Developmental Immunology|January 11, 2013
The clinical significance of the dense fine speckled immunofluorescence pattern on HEp-2 cells for the diagnosis of systemic autoimmune diseasesMichael Mahler, Marvin J Fritzler
Annals of the Rheumatic Diseases|August 1, 2019
Augmented versus artificial intelligence for stratification of patients with myositisMichael Mahler, Brenden Rossin, Olga Kubassova
Pageof 21